0.2216
전일 마감가:
$0.2343
열려 있는:
$0.23
하루 거래량:
1.82M
Relative Volume:
0.97
시가총액:
$27.69M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-0.1351
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
+27.72%
1개월 성능:
-66.50%
6개월 성능:
-75.54%
1년 성능:
-84.50%
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VOR
Vor Biopharma Inc
|
0.2216 | 21.68M | 0 | -112.46M | -99.89M | -1.64 |
![]()
ONC
Beone Medicines Ltd Adr
|
251.72 | 25.78B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
446.48 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.3401 | 40.54M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
84.81 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
487.86 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-07-26 | 개시 | Wedbush | Outperform |
2022-04-27 | 개시 | Goldman | Neutral |
2021-12-17 | 개시 | H.C. Wainwright | Buy |
2021-12-03 | 개시 | Robert W. Baird | Outperform |
2021-12-02 | 개시 | Oppenheimer | Outperform |
2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
2021-03-25 | 개시 | B. Riley Securities | Buy |
2021-03-03 | 개시 | Barclays | Overweight |
2021-03-03 | 개시 | Evercore ISI | Outperform |
2021-03-02 | 개시 | Goldman | Sell |
2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Northern Trust Corp Acquires 44,252 Shares of Vor Biopharma Inc. (NYSE:VOR) - Defense World
Cambridge biotech company researching blood cancers to close, lay off 155 - Yahoo Finance
Vor Biopharma Inc (NASDAQ: VOR) Stock Forecast: Could Pass $6 In A Year - Stocksregister
Vor Biopharma’s SWOT analysis: biotech firm halts programs, explores options - Investing.com
Vor Biopharma Approves Share Increase at Annual Meeting - TipRanks
Vor Biopharma Appoints Robert Ang as CFO - TipRanks
What Did We Note About Insider Trading At Vor Biopharma Inc (NASDAQ: VOR)? - Stocksregister
FMR LLC's Strategic Acquisition of Vor Biopharma Inc Shares - GuruFocus
Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Hold” by Analysts - Defense World
Vor Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Vor Biopharma Inc. SEC 10-Q Report - TradingView
Research Analysts’ Recent Ratings Updates for Vor Biopharma (VOR) - Defense World
Vor Biopharma (NYSE:VOR) Cut to “Hold” at Jones Trading - Defense World
HC Wainwright Reaffirms Neutral Rating for Vor Biopharma (NYSE:VOR) - Defense World
Vor Biopharma’s (VOR) Neutral Rating Reiterated at Wedbush - Defense World
Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy t - GuruFocus
VorBio (VOR) Downgraded Amid Strategic Review Announcement | VOR Stock News - GuruFocus
Vor Biopharma (VOR) Drops Sharply After Downgrades and Operational Halt - GuruFocus
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns By Investing.com - Investing.com South Africa
VorBio (VOR) Downgraded as Company Explores Strategic Alternativ - GuruFocus
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns - Investing.com Canada
Vor Biopharma stock draws downgrades (VOR:NASDAQ) - Seeking Alpha
Layoff Tracker: Shape, Vor Cut Workforces - BioSpace
Vor Biopharma (VOR) Downgraded by JMP Securities | VOR Stock New - GuruFocus
Baird Downgrades Vor Biopharma to Neutral From Outperform - marketscreener.com
This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Vor Biopharma (VOR) Downgraded by HC Wainwright & Co. from Buy to Neutral | VOR Stock News - GuruFocus
Closing Bell Recap: Vor Biopharma Inc (VOR) Ends at 0.16, Reflecting a -70.12 Downturn - DWinneX
VorBio (VOR) Downgraded as Company Shifts Strategy | VOR Stock News - GuruFocus
VorBio (VOR) Downgraded as Company Explores Strategic Alternatives | VOR Stock News - GuruFocus
Stifel Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider
Baird cuts Vor Biopharma stock rating, slashes target to $0.25 By Investing.com - Investing.com Nigeria
Baird cuts Vor Biopharma stock rating, slashes target to $0.25 - Investing.com
Jones Trading cuts Vor Biopharma stock rating to Hold By Investing.com - Investing.com Nigeria
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga
Jones Trading cuts Vor Biopharma stock rating to Hold - Investing.com
Vor Biopharma stock plummets on operation wind-down - Investing.com Australia
Vor Biopharma stock plummets on operation wind-down By Investing.com - Investing.com Canada
Vor Biopharma Terminates CFO Han Choi - marketscreener.com
Vor Bio Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value - marketscreener.com
Wedbush Downgrades Vor Biopharma to Neutral From Outperform, Adjusts Price Target to $0.40 From $7 - marketscreener.com
Vor Bio (VOR) Downgraded to Hold as Strategic Alternatives Explored | VOR Stock News - GuruFocus
Jones Trading Downgrades Vor Biopharma, Inc. (VOR) to Hold - StreetInsider
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall - Benzinga
Vor Bio (VOR) Explores Strategic Alternatives Amid Operational Wind Down | VOR Stock News - GuruFocus
Vor Biopharma (VOR) Announces Exploration of Strategic Alternatives, Winding Down Operations - StreetInsider
Marshall Wace LLP Sells 79,445 Shares of Vor Biopharma Inc. (NYSE:VOR) - Defense World
Vor Biopharma Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
XTX Topco Ltd Acquires New Position in Vor Biopharma Inc. (NYSE:VOR) - The AM Reporter
Crescent Biopharma Appoints David Lubner to Board of Directors - The Manila Times
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) - The Globe and Mail
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):